Free Trial
→ The most productive 1 min of your day… (From Timothy Sykes) (Ad) Free CTMX Stock Alerts

CytomX Therapeutics (CTMX) ESG Score & Sustainability Data

CytomX Therapeutics logo
$1.00
0.00 (0.00%)
(As of 10/31/2024 ET)
Compare

Key ESG Takeaways for CytomX Therapeutics

The key takeaways are AI-generated and highlight the main contributors behind the net impact scores of CytomX Therapeutics. The insights are based on millions of scientific articles, along with the company-specific product and service portfolio.
  • CytomX Therapeutics seems to create the most significant positive value in categories , , and . The largest positive contribution comes from its impact, which is driven by its Preclinical research services for physical health, Basic medical research services, and Clinical research services for cancer products.
  • CytomX Therapeutics uses resources or causes negative impacts mostly in categories , , and . The negative contribution in the impact category is driven by its Clinical research services for cancer, Preclinical research services for physical health, and Basic medical research services products.
  • To improve its net impact, a company can either grow its positive impacts, or reduce its negative impacts. For example, by doubling its Preclinical research services for physical health business, CytomX Therapeutics would improve its net impact ratio by 0 percentage points.

CTMX Impact Ratio

Net impact ratio represents the net impact of a company. It is defined as the (positive impacts - negative impacts) / positive impacts. The maximum value for net impact ratio is 100%, representing a theoretical company with no negative impacts. The minimum value is -∞. Net scores depend on the value sets that determine the importance of different impact categories.
+74.2%
The default value set, where each category is given the same weight.

Value Sets Value sets can be used to assess how different stakeholder values or emphasis on certain values might affect the net impact ratio.

Millennials
Value set of millennials (b. 1980 - 1999), based on Upright's annual Impact at Work survey.
+77.8%
Most Wanted Workforce
Value set of the most wanted workforce, based on Upright's annual Impact at Work survey.
+70.7%
Society First
Value set that emphasizes society impacts over other impacts.
+51.5%
Knowledge First
Value set that emphasizes knowledge impacts over other impacts.
+89.5%
Health First
Value set that emphasizes health impacts over other impacts.
+85.9%

CytomX Therapeutics ESG Score + Net Impact Profile

ImpactNegativeScorePositive
+1.27
+1.27
+1.64
+1.64
+0.00
+0.00
-0.01
-0.01
+0.00
-0.00
+0.22
+0.22
+0.00
+0.00
+3.83
+3.83
-0.00
+0.00
+0.00
-1.88
-1.88
-0.26
+3.47
+3.73
-0.03
+0.43
+0.46
0.00
+0.00
-0.00
+0.00
+0.01
-0.00
+0.17
+0.17
-0.41
-0.41
+0.00
-0.02
-0.02
+0.00
-0.01
-0.01
+0.00
-0.01
-0.01
+0.00
-0.28
-0.28
+0.00

Upright Model Version 0.7.0
ESG Data Last Updated: December 8, 2022

Ad WealthPress
This man believes TSLA will reach $500 a share…
Even though shares of Tesla are only up 3% this year, one man believes Tesla’s next bull run is just around the corner. In his professional opinion, the share price could reach $500 or more… Now, we understand that may seem far-fetched, but as you’ll see in his new ebook, it’s not as crazy as it may sound. In fact, he argues a Trump presidency could make it happen much faster than you might think. which is why we’re emailing you now… For the time being, he’s giving away his Tesla ebook for free. Inside explains how shares could reach $500 in the near future.
To claim your copy, follow this link

About Upright's Net Impact Model

Upright Model

Upright's Net Impact Data quantifies the holistic value creation and impact of companies. It details both the negative and positive impacts a company has on the environment, health of people, society and knowledge, and forms a net sum of these costs and gains based on the economic costs of each impact category. The data is produced by Upright's Net Impact model, which is a mathematical model of the economy that produces continuously updated estimates of the net impact of companies by means of an information integration algorithm. The data is primarily sourced from the CORE open access database, which contains over 200 million scientific papers. Other sources of data include open databases published by the World Bank, IMF, WHO, OECD, IPCC, CDC and USDA.

CytomX Therapeutics ESG Score - Frequently Asked Questions

How is CytomX Therapeutics doing in terms of sustainability?

According to The Upright Project, which measures holistic value creation and impact of companies, CytomX Therapeutics has a net impact ratio of 74.2%, indicating an overall positive sustainability impact. CytomX Therapeutics seems to create the most significant positive value in the categories of Creating knowledge, Physical diseases, and Taxes. CytomX Therapeutics uses resources or causes negative impacts mostly in the categories of Scarce human capital, GHG emissions, and Waste. Learn more on the sustainability of CytomX Therapeutics.


More ESG Stocks and Research Tools

Related Companies
Stock Lists
Sustainability Tools

This page (NASDAQ:CTMX) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...
Traders Agency | Sponsored
Nvidia is Pivoting to Solve Big Tech’s $1 Trillion Problem
Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...
Weiss Ratings | Sponsored
“Buffett Indicator” Predicts 62% Stock Market Crash
The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.
Behind the Markets | Sponsored
Trump or Kamala? It may come down to this strange twist…
Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...
Porter & Company | Sponsored
625,000% Gain
The recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...
Crypto Swap Profits | Sponsored
Gold at $2,600... But This Stock Gives You More for Under $20
Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...
Monument Traders Alliance | Sponsored
CNBC’s ‘Prophet’ issues urgent Fed warning
"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...
Stansberry Research | Sponsored